[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368288-105":59,"doc-detail-368288-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rising-incidence-trends-of-synchronous-prostate-and-rectal-cancers-a-population-based-study","Rising incidence trends of synchronous prostate and rectal cancers - a population-based study","","Background: Lack of comprehensive reporting on time trends in synchronous prostate and rectal cancers motivated a large population-based cohort study. Methods: Adult men with incident prostate cancer in the Swedish Cancer Register (1993–2019) were analyzed using age-standardized incidence rates and Poisson regression, comparing synchronous disease (within ±6 months of rectal diagnosis) and sensitivity analyses with non-sigmoid colon cancers. Results: Among 238,252 cases, 594 were synchronous; incidence rose and synchronous-to-general IRRs increased. Interpretation: Incidence increased over ~20 years in Sweden without plateauing, warranting research on overdiagnosis and improved management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rising-incidence-trends-of-synchronous-prostate-and-rectal-cancers-a-population-based-study/368288/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rising-incidence-trends-of-synchronous-prostate-and-rectal-cancers-a-population-based-study/368288.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main objective regarding synchronous prostate and rectal cancers?","Question",{"text":112,"@type":113},"To assess long-term incidence trends of synchronous prostate and rectal cancers using a population-based cohort in Sweden.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers define “synchronous” prostate cancer in relation to rectal cancer?",{"text":117,"@type":113},"Synchronous prostate cancer was defined as prostate cancer diagnosed within ±6 months of the rectal cancer diagnosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about incidence trends over 1993–2019?",{"text":121,"@type":113},"The incidence of synchronous prostate cancer increased, and the synchronous-to-general incidence rate ratio rose from 1.92 to 2.61 over the same periods, with no signs of plateauing.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368288,1790356091,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","ORIGINAL ARTICLE  \nRising incidence trends of synchronous prostate and rectal cancers: a populationbased study  \nElias Edfelta, Mehrnoosh Shahrivarb,c, Karin Holmstenc,d and Cecilia Radkiewicza,c  \na Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; bColorectal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; c Department of Surgery and Oncology, Capio Sankt Görans Hospital, Stockholm, Sweden; dDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden  \nABSTRACT  \nBackground: There is a lack of comprehensive reports on time trends in synchronous prostate and rectal cancers. To address this, we conducted the largest cohort study to date to assess these trends in a population-based setting.  \nMethods: We included all adult (ages 18−99) men with incident prostate cancer in the Swedish Cancer Register in 1993−2019 . Age-standardized incidence rates (ASIRs) of prostate cancer per 100,000 male population per year were calculated and compared to the ASIR of synchronous (± 6 months from rectal cancer diagnosis) prostate cancer. Age-adjusted synchronous-to-general incidence rate ratios (IRRs) were predicted using Poisson regression. As a sensitivity analysis to assess the effect of incidental findings due to the anatomical proximity, we investigated synchronous prostate and non-sigmoid colon cancers.  \nResults: Among 238,252 prostate cancer cases, 594 were synchronous with rectal cancer. The incidence of synchronous prostate cancer increased over the study period, with mean ASIR rising from 418/100,000 (1993−2001) to 788/100,000 (year 2011−2019). The synchronous-to-general IRR increased from 1.92 (95% confidence interval (CI) 1.60−2.31) to 2.61 (95% CI 2.32−2.95) over the same periods. Prostate cancer was also more commonly diagnosed in conjunction with non-sigmoid colon cancer than in the overall male population, but no time trend was observed.  \nInterpretation: The incidence of synchronous prostate and rectal cancers has increased over the past 20 years in Sweden, with no signs of plateauing. Future studies are warranted to explore factors contributing to prostate cancer overdiagnosis and to optimize clinical management strategies for this complex patient group.  \nARTICLE HISTORY  \nReceived 28 November 2024  \nAccepted 24 January 2024 Published 7 March 2025  \nKEYWORDS  \nIncidence; multiple primary neoplasms; synchronous; prostate cancer; rectal cancer  \nIntroduction  \nGlobally, prostate and colorectal cancers rank the second and third most common malignancies in men, respectively [1]. While the incidence of these cancers has been rising over recent decades, the trend (both malignancies) has stabilized in Human Development Index high countries in the past decade [1] . Age and family history are key risk factors for both cancers, whereas lifestyle and dietary factors, such as sedentary behaviors and animal-source foods, are more prominently associated with colorectal cancer [1–3]. Approximately 30% of colorectal tumors are located in the rectum [4] . Pelvic magnetic resonance imaging (MRI) is routinely used for diagnosing and staging both prostate and rectal cancers [5, 6] . Pelvic MRI is however not standard for colon cancer diagnosis, and tumors in the colon, except for distal (borderline rectal) sigmoid tumors, are typically undetected using pelvic MRI. Reports on synchronous prostate and rectal cancer are scarce, and comprehensive, population-based studies assessing long-term trends are lacking [7–12] . Available  \nevidence suggests an increasing incidence of synchronous prostate cancer in men with rectal cancer, likely driven by incidental prostate tumors detected on rectal cancer staging MRI [11] .  \nSynchronous prostate and rectal cancers pose significant clinical challenges. Due to their anatomical proximity, concurrent curative treatments carry a higher risk of locoregional adverse events [1","cbCais6KiS4EdhGd","https://ap.wps.com/l/cbCais6KiS4EdhGd","pdf",857102,"English","# Abstract\n# Introduction\n## Epidemiology and risk factors\n## Clinical challenges and knowledge gaps\n# Conclusion\n# Material and methods","[{\"question\":\"What was the study’s main objective regarding synchronous prostate and rectal cancers?\",\"answer\":\"To assess long-term incidence trends of synchronous prostate and rectal cancers using a population-based cohort in Sweden.\"},{\"question\":\"How did the researchers define “synchronous” prostate cancer in relation to rectal cancer?\",\"answer\":\"Synchronous prostate cancer was defined as prostate cancer diagnosed within ±6 months of the rectal cancer diagnosis.\"},{\"question\":\"What were the key findings about incidence trends over 1993–2019?\",\"answer\":\"The incidence of synchronous prostate cancer increased, and the synchronous-to-general incidence rate ratio rose from 1.92 to 2.61 over the same periods, with no signs of plateauing.\"}]","Rising incidence trends of synchronous prostate and rectal cancers - a population-based study | PDF",1790176039,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47896cbe1eb473d82982dcb502ed8349.webp",983,1280,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48adadef33680c52d24a3dcc862b7728.webp",982,1278,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ae02d50c3207f77205818a5f9200523.webp",981,1277,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1835e58a0d394dadf4a48cde825aefbf.webp",980,1276]